Highly resistant E. coli strain found in NYC hospital patients

Mackenzie Bean - Print  | 

Researchers identified a highly resistant strain of Escherichia coli in four patients at a hospital in New York City, according to a study published in Antimicrobial Agents and Chemotherapy.

The E. coli strain contains a gene called mcr-1, which renders the bacteria resistant to colistin — an antibiotic of last resort for many drug-resistant infections.

Researchers identified the bacteria while monitoring patients with weakened immune systems as part of a prospective surveillance study. Three of the patients harboring the antibiotic-resistant E. coli strain exhibited no symptoms of infection, which increases the risk of unknowingly spreading the bacteria to others.

"While mcr-1 has been described from other parts of the world, it has been very rare in the U.S.," lead author Anne-Catrin Uhlemann, MD, PhD, associate professor at Columbia University's Vagelos College of Physicians and Surgeons in New York City, said in a press release.

"The detection of this cluster demonstrates the potential for silent dissemination of mcr-1 in the U.S. hospital setting, through asymptomatic colonization," Dr. Uhlemann added. "Our findings represent the earliest known documented healthcare-associated cluster of mcr-1 in the United States and predates a recent report that occurred in 2017."

More articles on clinical leadership and infection control: 

CDC's secrecy of drug-resistant outbreaks in hospitals sparks patient safety debate
Cases of deadly fungal infection in US rise to 587
Bill to expand NPs' practice scope advances in California legislature

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.